NSC |
Compound |
Enrichment |
Correlation |
NSC 703315 |
Null |
0.0115521552688255 |
0.25420737 |
NSC 709925 |
Null |
0.0115521552688255 |
-0.076579104 |
NSC 712733 |
Null |
0.0115521552688255 |
0.38352897 |
NSC 728132 |
1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene |
0.0115521552688255 |
0.51389842 |
NSC 744020 |
methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate |
0.0115521552688255 |
0.2293396 |
NSC 747252 |
Trihexyl(tetradecyl)Phosphonium Hexafluorophosphate |
0.0115521552688255 |
0.38810763 |
NSC 758965 |
CEPHARANTHINE |
0.0115521552688255 |
0.3141927 |
NSC 46691 |
Null |
0.0115521552688258 |
-0.32552879 |
NSC 603086 |
2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- |
0.0115521552688258 |
0.59018706 |
NSC 617823 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.0115521552688258 |
0.5974144 |